Wnt signaling in hepatocellular carcinoma: Analysis of mutation and expression of beta-catenin, T-cell factor-4 and glycogen synthase kinase 3-beta genes

Journal of Gastroenterology and Hepatology (Australia)

Volumn 18, Issue 3, 2003, Pages 280-287

  Cui, Jian ^a,b   Zhou, Xinda ^a   Liu, Yinkun ^a   Tang, Zhaoyou ^a   Romeih, Mahmoud ^b  

^a FUDAN UNIVERSITY   (China)

^b MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Etiology; Liver; Neoplasm; Signal transduction

Indexed keywords

BETA CATENIN; CYCLIN D1; DNA; GLYCOGEN SYNTHASE KINASE 3BETA; MESSENGER RNA; MYC PROTEIN; T CELL FACTOR 4; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; WNT PROTEIN;

ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; CYTOPLASM; DNA SEQUENCE; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; NUCLEOTIDE SEQUENCE; ONCOGENE C MYC; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SINGLE STRAND CONFORMATION POLYMORPHISM;

EID: 0037367866     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.2003.02973.x     Document Type: Article

References (26)

1. Murray CJL, Lopez AD. Mortality by cause for eight regions of the world: global burden of disease study. Lancet 1997; 349: 1269-76.
2. de La Coste A, Romagnolo B, Billuart P et al. Somatic mutations of the β-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc. Natl Acad. Sci. USA 1998; 95: 8847-51.
3. Cui J, Zhou XD, Liu YK, Tangt ZY, Zile MH. Abnormal β-catenin gene expression with invasiveness of primary hepatocellular carcinoma in China. World. J. Gastroenterol. 2001; 7: 542-6.
4. Cui J, Zhou XD, Liu YK, Tang ZY. Mutation and over expression of β-catenin gene may play an important role in primary hepatocellular carcinoma among Chinese people. J. Cancer Res. Clin. Oncol. 2001; 127: 577-81.
5. Pennisi E. How a growth control path takes a wrong turn to cancer. Science 1998; 281: 1438-41.
6. Polakis P. The adenomatous polyposis coli (APC) tumor suppressor. Biochim. Biophys. Acta 1997; 1332: F127-47.
7. Clevers H, van de Wetering M. TCF/LEF factors earn their wings. Trends Genet. 1997; 13: 485-9.
8. Piao Z, Kim H, Jeon BK, Lee WJ, Park C. Regulation between loss of heterozygosity of tumor suppresser gene and histological differentiation in hepatocellular carcinoma. Cancer 1997; 80: 865-72.
9. Satoh S, Daigo Y, Furukawa Y et al. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1. Nat. Genet. 2000; 24: 245-50.
10. Takayasu H, Horie H, Hiyama E et al. Frequent deletions and mutations of the β-catenin gene are associated with overexpression of Cyclin D1 and fibronectin and poorly differentiated histology in childhood hepatoblastoma. Clin. Cancer Res. 2001; 7: 901-8.
11. Van Aken E, De Wever O, Correia da Rocha AS, Mareel M. Defective E-cadherin/catenin complexes in human cancers. Virchows Arch. 2001; 439: 725-51.
12. Wong CM, Fan ST, Ng IOL. β-catenin mutation and overexpression in hepatocellular carcinoma. Cancer 2001; 92: 136-45.
13. Huang H, Fujii H, Sankila A et al. β-catenin mutations are frequent in human hepatocellular carcinomas associated with hepatitis C virus infection. Am. J. Pathol. 1999; 155: 1795-801.
14. Yu SZ. Primary prevention of hepatocellular carcinoma. J. Gastroenterol. Hepatol. 1995; 10: 674-82.
15. Tang ZY. Hepatocellular carcinoma - Cause, treatment and metastasis, World J. Gastroenterol. 2001; 7: 445-54.
16. Sekijima M, Tsutsumi T, Yoshida T et al. Enhancement of glutathione S-transferase placental-form positive liver cell foci development by microcystin-LR in aflatoxin B1-initiated rats. Carcinogenesis 1999; 20: 161-5.
17. Devereux TR, Stern MC, Flake GPYuMC, Zhang ZQ, London SJ et al. CTNNB1 mutations and beta-catenin protein accumulation in human hepatocellular carcinomas associated with high exposure to aflatoxin B1. Mol. Carcinog. 2001; 31: 68-73.
18. Xu XR, Huang J, Xu ZG et al. Insight into hepatocellular carcinogenesis at transcriptome level by comparing gene expression profiles of hepatocellular carcinoma with those of corresponding noncancerous liver. Proc. Natl Acad. Sci. USA 2001; 98: 15 089-94.
19. Iizuka N, Oka M, Yamada-Okabe H et al. Comparison of gene expression profiles between hepatitis B virus- and hepatitis C virus-infected hepatocellular carcinoma by oligonucleotide microarray data on the basis of a supervised learning method. Cancer Res. 2002; 62: 3939-44.
20. Sparks AB, Morin PJ, Vogestein B, Kinzler KW. Mutational analysis of the APC/β-catenin /Tcf pathway in colorectal cancer. Cancer Res. 1998; 58: 1130-4.
21. Korinek V, Barker N, Moerer P et al. Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4. Nat. Genet. 1998; 19: 379-83.
22. Duval A, Rolland S, Tubacher E, Bui H, Thomas G, Hamelin R. The human T-cell transcription factor-4 gene: structure, extensive characterization of alternative splicings, and mutational analysis in colorectal cancer cell lines. Cancer Res. 2000; 60: 3872-9.
23. Di Bisceglie AM. Hepatocellular carcinoma: molecular biology of its growth and relationship to hepatitis B virus infection. Med. Clin. North Am. 1989; 73: 985-97.
24. Monga SP, Pediaditakis P, Mule K, Stolz DB, Michalopoulos GK. Changes in WNT/β-catenin pathway during regulated growth in rat liver regeneration. Hepatology 2001; 33: 1098-109.
25. Gottardi CJ, Wong E, Gumbiner BM. E-cadherin suppresses cellular transformation by inhibiting β-catenin signaling in an adhesion-independent manner. J. Cell Biol. 2001; 153: 1049-60.
26. Huber O, Bierkamp C, Kemle R. Cadherins and catenins in development. Curr. Opin. Cell Biol. 1996; 8: 685-91.